NASDAQ: DNTHDianthus Therapeutics Inc Stock Ownership - Who owns Dianthus Therapeutics?
Insider buying vs selling
Have Dianthus Therapeutics Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when DNTH insiders and whales buy or sell their stock.
DNTH Shareholders
What type of owners hold Dianthus Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Fairmount Funds Management LLC | 25.39% | 8,164,219 | $192.43M | Insider |
| Fmr LLC | 14.13% | 4,544,188 | $107.11M | Institution |
| Bruce Booth | 12.80% | 4,117,125 | $97.04M | Insider |
| Blake Byers | 10.38% | 3,339,137 | $78.70M | Insider |
| Gv 2016 GP LLC | 10.38% | 3,339,137 | $78.70M | Insider |
| Vestal Point Capital LP | 9.95% | 3,200,000 | $75.42M | Institution |
| Atlas Venture Fund X LP | 9.79% | 3,148,399 | $74.21M | Insider |
| Third Rock Ventures IV LP | 9.51% | 3,058,204 | $72.08M | Insider |
| Ra Capital Management LP | 8.91% | 2,866,733 | $67.57M | Institution |
| Lei Meng | 8.45% | 2,717,554 | $64.05M | Insider |
DNTH vs Biotech Stocks
Dianthus Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.